Read the latest Quest newsletter

QUEST is a FREE newsletter published three times a year by the Urological Research Foundation. It informs readers of the latest advances in urologic research, especially prostate cancer treatment.

Please click here to subscribe to QUEST.

QUEST is a free newsletter, but we appreciate your support in helping the URF bring this publication to its readers.

Long-Term Consequences of Finasteride versus Placebo

  Research efforts continue to assess the effectiveness and safety of finasteride, a drug used to treat hair loss in men (Propecia or generics) or enlarged prostate (Proscar or generics). Enlarged prostate is also known as benign prostatic hyperplastic, or…

Read More

Ralph Wozniak, an Engineer for Life

Ralph and Janet Wozniak married in 1965 when they were 21 and 20 years old, respectively. After graduating from the Illinois Institute of Technology with a degree in chemical engineering, Ralph took a position at Universal Oil Products (UOP), a…

Read More

ADT Type, Duration and the Risk of Diabetes

Arecent study investigated the association between the types and duration of androgen deprivation therapy (ADT, or hormone therapy) and the risk of type 2 diabetes. Researchers used data from the Prostate Cancer database Sweden and compared diabetes risk in 34,031…

Read More

Saturated Fat Linked to Aggressive Prostate Cancer

The study used data on 1,854 men diagnosed with prostate cancer between 2004 and 2009, including 321 (17%) with highly aggressive cancer. The participants were part of a larger study called the North Carolina-Louisiana Prostate Cancer Project. Men in the…

Read More

Subscribe to Quest